Growth factors in gliomas revisited

Acta Neurochirurgica

Volumn 142, Issue 2, 2000, Pages 113-138

  Hamel, W ^a   Westphal, M ^b  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Epidermal growth factor (EGF); erbB, vascular endothelial growth factor (VEGF); Fibroblast growth factor (FGF); Glioma; Growth factors; Hepatocyte growth factor (HGF); Insulin like growth factor (IGF); Oncogenes; Platelet derived growth factor (PDGF); Therapy

Indexed keywords

4 (3 BROMOANILINO) 6,7 DIMETHOXYQUINAZOLINE; BASIC FIBROBLAST GROWTH FACTOR; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; LEFLUNOMIDE; MUTANT PROTEIN; NEU DIFFERENTIATION FACTOR; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; SCATTER FACTOR; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR BETA; TYROSINE KINASE RECEPTOR; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; CELL DEATH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; GENE OVEREXPRESSION; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; ONCOGENE; PRIORITY JOURNAL; PROTO ONCOGENE; RECEPTOR GENE; REVIEW;

EID: 0033952759     PISSN: 00016268     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007010050015     Document Type: Review

References (358)

1. Aiken R, Andrews D, Resnicoff M, Baserga R (1998) Treatment of patients with malignant astrocytomas using subcutaneously implanted diffusion chambers containing autologous tumour suspensions preincubated with IGF-1R antisense DNA. Society for Neuro-Oncology, Third Annual Scientific Meeting, San Francisco, CA, Abstract No. 2
2. Alimandi M, Romano A, Curia MC, Muraro R, Fedi P, Aaronson SA, Di Fiore PP et al (1995) Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas. Oncogene 10: 1813-1821
3. Antoniades HN, Galanopoulos T, Neville-Golden J, Maxwell M (1992) Expression of insulin-like growth factors I and II and their receptor mRNAs in primary human astrocytomas and meningiomas; in vivo studies using in situ hybridization and immunocytochemistry. Int J Cancer 50: 215-222
4. Antonyak MA, Moscatello DK, Wong AJ (1998) Constitutive activation of c-Jun N-terminal kinase by a mutant epidermal growth factor receptor. J Biol Chem 273: 2817-2822
5. Asahara T, Bauters C, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF et al (1995) Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 92: II365-II371
6. Ashley DM, Batra SK, Bigner DD (1997) Monoclonal antibodies to growth factors and growth factor receptors: their diagnostic and therapeutic potential in brain tumours. J Neurooncol 35: 259-273
7. Ballotti R, Nielsen FC, Pringle N, Kowalski A, Richardson WD, Van Obberghen E, Gammeltoft S (1987) Insulin-like growth factor I in cultured rat astrocytes: expression of the gene, and receptor tyrosine kinase. EMBO J 6: 3633-3639
8. Baserga R (1995) The insulin-like growth factor I receptor: a key to tumour growth? Cancer Res 55: 249-252
9. Baskin DG, Wilcox BJ, Figlewicz DP, Dorsa DM (1988) Insulin and insulin-like growth factors in the CNS. Trends Neurosci 11: 107-111
10. Bates P, Fisher R, Ward A, Richardson L, Hill DJ, Graham CF (1995) Mammary cancer in transgenic mice expressing insulin-like growth factor II (IGF-II). Br J Cancer 72: 1189-1193
11. Batra SK, Castelino-Prabhu S, Wikstrand CJ, Zhu X, Humphrey PA, Friedman HS, Bigner DD (1995) Epidermal growth factor ligand-independent, unregulated, cell-transforming potential of a naturally occurring human mutant EGFRvIII gene. Cell Growth Differ 6: 1251-1259
12. Beckmann MP, Betsholtz C, Heldin CH, Westermark B, Di Marco E, Di Fiore PP, Robbins KC et al (1988) Comparison of biological properties and transforming potential of human PDGF-A and PDGF-B chains. Science 241: 1346-1349
13. Behl C, Winkler J, Bogdahn U, Meixensberger J, Schligensiepen KH, Brysch W (1993) Autocrine growth regulation in neuroectodermal tumours as detected with oligodeoxynucleolide antisense molecules. Neurosurgery 33: 679-684
14. Bejcek BE, Hoffman RM, Lipps D, Li DY, Mitchell CA, Majerus PW, Deuel TF (1992) The v-sis oncogene product but not platelet-derived growth factor (PDGF) A homodimers activate PDGF alpha and beta receptors intracellularly and initiate cellular transformation. J Biol Chem 267: 3289-3293
15. Bejcek BE, Li DY, Deuel TF (1989) Transformation by v-sis occurs by an internal autoactivation mechanism. Science 245: 1496-1499
16. Berdel WE, De Vos S, Maurer J, Oberberg D, von Marschall Z, Schroeder JK, Li J et al (1992) Recombinant human stem cell factor stimulates growth of a human glioblastoma cell line expression c-kit protooncogene. Cancer Res 52: 3502-4398
17. Betsholtz C, Johnsson A, Heldin CH, Westermark B (1986) Efficient reversion of simian sarcoma virus-transformation and inhibition of growth factor-induced mitogenesis by suramin. Proc Natl Acad Sci USA 83: 6440-6444
18. Betsholtz C, Johnsson A, Heldin CH, Westermark B, Lind P, Urdea MS, Eddy R et al (1986) cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumour cell lines. Nature 320: 695-699
19. Bigner SH, Humphrey PA, Wong AJ, Vogelstein B, Mark J, Friedman HS, Bigner DD (1990) Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts. Cancer Res 50: 8017-8022
20. Bigner SH, Mark J, Bigner DD (1990) Cytogenetics of human brain tumours. Cancer Genet Cytogenet 47: 141-154
21. Bodmer S, Strommer K, Frei K, Siepl C, de Tribolet N, Heid I (1989) Immunosuppression and transforming growth factor-beta in glioblastoma. Preferential production of transforming growth factor-beta 2. J Immunol 143: 3222-3229
22. Bogler O, Wren D, Barnett SC, Land H, Noble M (1990) Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells. Proc Natl Acad Sci USA 87: 6368-6372
23. Borgstrom P, Hillan KJ, Sriramarao P, Ferrara N (1996) Complete inhibition of angiogenesis and growth of microtumours by anti-vascular endothelial growth factor neutralizing antibody: novel concepts of angiostatic therapy from intravital videomicroscopy. Cancer Res 56: 4032-4039
24. Bosenberg MW, Massague J (1993) Juxtacrine cell signaling molecules. Curr Opin Cell Biol 5: 832-838
25. Bottaro DP, Rubin JS, Faletto DL, Chan AML, Kmiecik TE, Vande W, Aaronson SA (1991) Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251: 802-804
26. Brady LW, Miyamoto C, Woo DV, Rackover M, Emrich J, Bender H, Dadparvar S et al (1992) Malignant astrocytomas treated with iodine-125 labeled monoclonal antibody 425 against epidermal growth factor receptor: a phase II trial. Int J Radiat Oncol Biol Phys 22: 225-230
27. Braulke T (1999) Type-2 IGF receptor: a multi-ligand binding protein. Horm Metab Res 31: 242-246
28. Bredel M, Pollack IF, Campbell JW, Hamilton RL (1997) Basic fibroblast growth factor expression as a predictor of prognosis in pediatric high-grade gliomas. Clin Cancer Res 3: 2157-2164
29. Bredel M, Pollack IF, Freund JM, Hamilton AD, Sebti SM (1998) Inhibition of ras and related G proteins as a therapeutic strategy for blocking malignant glioma growth. Neurosurgery 43: 124-132
30. Breier G, Clauss M, Risau W (1995) Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development. Dev Dyn 204: 228-239
31. Brem S, Cotran R, Folkman J (1972) Tumour angiogenesis: a quantitative method for histologic grading. J Natl Cancer Inst 48: 347-356
32. Brem S, Tsanaclis AM, Gately S, Gross JL, Herblin WF (1992) Immunolocalization of basic fibroblast growth factor to the microvasculature of human brain tumours. Cancer 70: 2673-2680
33. Britsch S, Li L, Kirchhoff S, Theuring F, Brinkmann V, Birchmeier C, Riethmacher D (1998) The ErbB2 and ErbB3 receptors and their ligand, neuregulin-1, are essential for development of the sympathetic nervous system. Genes Dev 12: 1825-1836
34. Brodeur GM, Maris JM, Yamashiro DJ, Hogarty MD, White P (1997) Biology and genetics of human neuroblastomas. J Pediatr Hematol Oncol 19: 93-101
35. Brodeur GM, Nakagawara A, Yamashiro DJ, Ikegaki N, Liu XG, Azar CG, Lee CP et al (1997) Expression of TrkA, TrkB and TrkC in human neuroblastomas. J Neurooncol 31: 49-55
36. Bruce JN, Criscuolo GR, Merrill MJ, Moquin RR, Blacklock J, B., Oldfield E, H. (1987) Vascular permeability induced by protein product of malignant brain tumours: inhibition by dexamethasone. J Neurosurg 67: 880-884
37. Burke D, Wilkes D, Blundell TL, Malcolm S (1998) Fibroblast growth factor receptors: lessons from the genes. Trends Biochem Sci 23: 59-62
38. Bussolino F, Di R, M.F., Ziche M, Bocchietto E, Olivero M, Naldini L, Gaudino G et al (1992) Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 119: 629-641
39. Canoll PD, Musacchio JM, Hardy R, Reynolds R, Marchionni MA, Salzer JL (1996) GGF/neuregulin is a neuronal signal that promotes the proliferation and survival and inhibits the differentiation of oligodendrocyte progenitors. Neuron 17: 229-243
40. Carraway KLr, Cantley LC (1994) A neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling. Cell 78: 5-8
41. Carraway KLr, Sliwkowski MX, Akita R, Platko JV, Guy PM, Nuijens A, Diamonti AJ et al (1994) The erbB3 gene product is a receptor for heregulin. J Biol Chem 269: 14303-14306
42. Chen P, Gupta K, Wells A (1994) Cell movement elicited by epidermal growth factor receptor requires kinase and autophosphorylation but is separable from mitogenesis. J Cell Biol 124: 547-555
43. Chicoine MR, Madsen CL, Silbergeld DL (1995) Modification of human glioma locomotion in vitro by cytokines EGF, bFGF, PDGFbb, NGF, and TNF alpha. Neurosurgery 36: 1165-1171
44. Chiu IM, Reddy EP, Givol D, Robbins KC, Tronick SR, Aaronson SA (1984) Nucleotide sequence analysis identifiesthe human c-sis proto-oncogene as a structural gene for plateled-derived growth factor. Cell 37: 123-129
45. Chu CT, Everiss KD, Wikstrand CJ, Batra SK, Kung HJ, Bigner D (1997) Receptor dimerization is not a factor in the signalling activity of a transforming variant epidermal growth factor receptor (EGFRvIII). Biochem J 324: 855-861
46. Claesson-Welsh L, Eriksson A, Moren A, Severinsson L, Ek B, Ostman A, Betsholtz C et al (1988) cDNA cloning and expression of a human platelet-derived growth factor (PDGF) receptor specific for B-chain-containing PDGF molecules. Mol Cell Biol 8: 3476-3486
47. Collins T, Ginsburg D, Boss JM, Orkin SH, Pober JS (1985) Cultured human endothelial cells express platelet-derived growth factor B chain: cDNA cloning and structural analysis. Nature 316: 748-750
48. Collins VP (1994) Epidermal growth factor receptor gene and its transcripts in glioblastomas. Recent Results Cancer Res 135: 17-24
49. Collins VP (1995) Gene amplification in human gliomas. Glia 15: 289-296
50. Conn G, Bayne ML, Soderman DD, Kwok PW, Sullivan KA, Palisi TM, Hope DA et al (1990) Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor. Proc Natl Acad Sci USA 87: 2628-2632
51. Coomber BL (1995) Suramin inhibits C6 glioma-induced angiogenesis in vitro. J Cell Biochem 58: 199-207
52. Coppola D, Ferber A, Miura M, Sell C, D'Ambrosio C, Rubin R, Baserga R (1994) A functional insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor. Mol Cell Biol 14: 4588-4595
53. Criscuolo GR, Merrill MJ, Oldfield EH (1988) Further characterization of malignant glioma-derived vascular permeability factor. J Neurosurg 69: 254-262
54. Crovello CS, Lai C, Cantley LC, Carraway KLr (1998) Differential signaling by the epidermal growth factor-like growth factors neuregulin-1 and neuregulin-2. J Biol Chem 273: 26954-26961
55. Cuvillier P, Pirianov G, Kleuser B, Vanek PG, Coso OA, Gutkind S, Spiegel S (1996) Suppression of ceramide-mediated programmed cell death by spingosine-1-phosphate. Nature 381: 800-803
56. Dalla-Favera R, Gelmann EP, Gallo RC, Wong-Staal F (1981) A human one gene homologous to the transforming gene (v-sis) of simian sarcoma virus. Nature 292: 31-35
57. Damert A, Machein M, Breier G, Fujita MQ, Hanahan D, Risau W, Plate KH (1997) Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms. Cancer Res 57: 3860-3864
58. de Martin R, Haendler B, Hofer-Warbinek R, Gaugitsch H, Wrann M, Schlusener H, Seifert JM et al (1987) Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-beta gene family. EMBO J 6: 3673-3677
59. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT (1992) The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255: 989-991
60. Deinhardt F (1980) Biology of primate retroviruses. In: Klein G (ed) Viral oncology. Raven Press, New York, pp 357-398
61. Di Marco E, Pierce JH, Fleming TP, Kraus MH, Molloy CJ, Aaronson SA, Di Fiore PP (1989) Autocrine interaction between TGFalpha and EGF-receptor: quantitative requirements for induction of the malignant phenotype. Oncogene 4: 831-838
62. Diedrich U, Lucius J, Baron E, Behnke J, Pabst B, Zoll B (1995) Distribution of epidermal growth factor receptor gene amplification in brain tumours and correlation to prognosis. J Neurol 242: 683-688
63. Doolittle RF, Hunkapiller MW, Hood LE, Devare SG, Robbins KC, Aaronson SA, Antoniades HN (1983) Simian sarcoma virus one gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor. Science 221: 275-277
64. Drago J, Murphy M, Carroll SM, Harvey RP, Bartlett PF (1991) Fibroblast growth factor-mediated proliferation of central nervous system precursors depends on endogenous production of insulin-like growth factor I. Proc Natl Acad Sci USA 88: 2199-2203
65. Dvorak HF, Sioussat TM, Brown LF, Berse B, Nagy JA, Sotrel A, Manseau EJ et al (1991) Distribution of vascular permeability factor (vascular endothelial growth factor) in tumours: concentration in tumour blood vessels. J Exp Med 174: 1275-1278
66. Eccleston PA, Silberberg DH (1985) Fibroblasl growth factor is a mitogen for oligodendrocytes in vitro. Brain Res 353: 315-318
67. Eilam R, Pinkas-Kramarski R, Ratzkin BJ, Segal M, Yarden Y (1998) Activity-dependent regulation of Neu differentiation factor/neuregulin expression in rat brain. Proc Natl Acad Sci USA 95: 1888-1893
68. Ekstrand AJ, James CD, Cavenee WK, Seliger B, Pettersson RF, Collins VP (1991) Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res 51: 2164-2172
69. Ekstrand AJ, Liu L, He J, Hamid ML, Longo N, Collins VP, James CD (1995) Altered subcellular location of an activated and tumour-associated epidermal growth factor receptor. Oncogene 10: 1455-1460
70. Ekstrand AJ, Longo N, Hamid ML, Olson JJ, Liu L, Collins VP, James CD (1994) Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification. Oncogene 9: 2313-2320
71. Ekstrand AJ, Sugawa N, James CD, Collins VP (1992) Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails. Proc Natl Acad Sci USA 89: 4309-4313
72. El-Obeid A, Bongcam-Rudloff E, Sorby M, Ostman A, Nister M, Westermark B (1997) Cell scattering and migration induced by autocrine transforming growth factor alpha in human glioma cells in vitro. Cancer Res 57: 5598-5604
73. Ellouk-Achard S, Djenabi S, De O, G.A., Desauty G, Duc H, Zohair M, Trojan J et al (1998) Induction of apoptosis in rat hepatocarcinoma cells by expression of IGF-I antisense c-DNA. J Hepatol 29: 807-818
74. Engebraaten O, Bjerkvig R, Pedersen PH, Laerum OD (1993) Effects of EGF, bFGF, NGF and PDGF(bb) on cell proliferative, migratory and invasive capacities of human brain-tumour biopsies in vitro. Int J Cancer 53: 209-214
75. Etienne MC, Formento JL, Lebrun-Frenay C, Gioanni J, Chatel M, Paquis P, Bernard C et al (1998) Epidermal growth factor receptor and labeling index are independent prognostic factors in glial tumour outcome. Clin Cancer Res 4: 2383-2390
76. Fakhrai H, Dorigo O, Shawler DL, Lin H, Mercola D, Black KL, Royston I et al (1996) Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy. Proc Natl Acad Sci USA 93: 2909-2914
77. Falls DL, Rosen KM, Corfas G, Lane WS, Fischbach GD (1993) ARIA, a protein that stimulates acetylcholine receptor synthesis, is a member of the neu ligand family. Cell 72: 801-815
78. Fantl WJ, Johnson DE, Williams LT (1993) Signalling by receptor tyrosine kinases. Annu Rev Biochem 62: 453-481
79. Feldkamp MM, Lau N, Guha A (1997) Signal transduction pathways and their relevance in human astrocytomas. J Neurooncol 35: 223-248
80. Ferrara N (1996) Vascular endothelial growth factor. Eur J Cancer 32A: 2413-2422
81. Ferrara N, Davis-Smyth T (1997) The biology of vascular endothelial growth factor. Endocr Rev 18: 4-25
82. Firsching A, Nickel P, Mora P, Allolio B (1995) Antiproliferative and angiostatic activity of suramin analogues. Cancer Research 55: 4957-4961
83. Fitzpatrick VD, Pisacane PI, Vandlen RL, Sliwkowski MX (1998) Formation of a high affinity heregulin binding site using the soluble extracellular domains of ErbB2 with ErbB3 or ErbB4. FEBS Lett 431: 102-106
84. Fleming TP, Matsui T, Heidaran MA, Molloy CJ, Artrip J, Aaronson SA (1992) Demonstration of an activated platelet-derived growth factor autocrine pathway and its role in human tumour cell proliferation in vitro. Oncogene 7: 1355-1359
85. Fleming TP, Matsui T, Molloy CJ, Robbins KC, Aaronson SA (1989) Autocrine mechanism for v-sis transformation requires cell surface localization of internally activated growth factor receptors. Proc Natl Acad Sci USA 86: 8063-8067
86. Fleming TP, Saxena A, Clark WC, Robertson JT, Oldfield EH, Aaronson SA, Ali IU (1992) Amplification and/or overexpression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumours. Cancer Res 52: 4550-4553
87. Fontana A, Bodmer S, Frei K, Malipiero U, Siepl C (1991) Expression of TGF-beta 2 in human glioblastoma: a role in resistance to immune rejection? Ciba Found Symp 157: 232-241
88. Fontana A, Frei K, Bodmer S, Hofer E, Schreier MH, Palladino MAJ, Zinkernagel RM (1989) Transforming growth factor-beta inhibits the generation of cytotoxic T cells in virus-infected mice. J Immunol 143: 3230-3234
89. Friesel RE, Maciag T (1995) Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction. FASEB J 9: 919-925
90. Gagliardi A, Hadd H, Collins DC (1992) Inhibition of angiogenesis by suramin. Cancer Res 52: 5073-5075
91. Gammeltoft S, Ballotti R, Kowalski A, Westermark B, Van Obberghen E (1988) Expression of two types of receptor for insulin-like growth factors in human malignant glioma. Cancer Res 48: 1233-1237
92. Gately S, Soff GA, Brem S (1995) The potential role of basic fibroblast growth factor in the transformation of cultured primary human fetal astrocytes and the proliferation of human glioma (U-87) cells. Neurosurgery 37: 723-732
93. Gately S, Tsanaclis AM, Takano S, Klagsbrun M, Brem S (1995) Cells transfecled with the basic fibroblast growth factor gene fused to a signal sequence are invasive in vitro and in situ in the brain. Neurosurgery 36: 780-788
94. Gazit A, Igarashi H, Chiu IM, Srinivasan A, Yaniv A, Tronick SR, Robbins KC et al (1984) Expression of the normal human sis/PDGF-2 coding sequence inducescellular transformation. Cell 39: 89-97
95. Gerber HP, Condorelli F, Park J, Ferrara N (1997) Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-I/KDR, is up-regulated by hypoxia. J Biol Chem 272: 23659-23667
96. Gerosa MA, Talarico D, Fognani C, Raimondi E, Colombatti M, Tridente G, De Carli L et al (1989) Overexpression of N-ras oncogene and epidermal growth factor receptor gene in human glioblastomas. J Natl Cancer Inst 81: 63-67
97. Gherardi E, Gray J, Stoker M, Perryman M, Furlong R (1989) Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement. Proc Natl Acad Sci USA 86: 5844-5848
98. Glick RP, Gettleman R, Patel K, Lakshman R, Tsibris JC (1989) Insulin and insulin-like growth factor I in brain tumours: binding and in vitro effects. Neurosurgery 24: 791-797
99. Glick RP, Lichtor T, Unterman TG (1997) Insulin-like growth factors in central nervous system tumours. J Neurooncol 35: 315-325
100. Glick RP, Unterman TG, Van der Woude M, Blaydes LZ (1992) Insulin and insulin-like growth factors in central nervous system tumours. Part V: Production of insulin-like growth factors I and II in vitro. J Neurosurg 77: 445-450
101. Goldberg MA, Schneider TJ (1994) Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J Biol Chem 269: 4355-4359
102. Goldman CK, Kim J, Wong W-L, King V, Brock T, Gillespie GY (1993) Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology. Mol Biol Cell 4: 121-133
103. Goldman R, Levy RB, Peles E, Yarden Y (1990) Heterodimerization of the erbB-1 and erbB-2 receptors in human breast carcinoma cells: a mechanism for receptor trans-regulation. Biochemistry 29: 11024-11028
104. Grant DS, Kleinman HK, Goldberg ID, Bhargava MM, Nickoloff BJ, Kinsella JL, Polverini P et al (1993) Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci USA 90: 1937-1941
105. Gronwald RG, Grant FJ, Haldeman BA, Hart CE, O'Hara PJ, Hagen FS, Ross R et al (1988) Cloning and expression of a cDNA coding for the human platelet-derived growth factor receptor: evidence for more than one receptor class. Proc Natl Acad Sci USA 85: 3435-3439
106. Guha A, Dashner K, Black PM, Wagner JA, Stiles CD (1995) Expression of PDGF and PDGF receptors in human astrocytoma operation specimens supports the existence of an autocrine loop. Int J Cancer 60: 168-173
107. Guha A, Feldkamp MM, Lau N, Boss G, Pawson A (1997) Proliferation of human malignant astrocytomas is dependent on Ras activation. Oncogene 15: 2755-2765
108. Guy PM, Platko JV, Cantley LC, Cerione RA, Carraway KLr (1994) Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity. Proc Natl Acad Sci USA 91: 8132-8136
109. Hamel W, Westphal M (1997) The road less travelled: c-kit and stem cell factor. J Neurooncol 35: 327-333
110. Hamel W, Westphal M, Shepard HM (1992) Proto-oncogene expression in human glioma derived cell lines. Int J Oncol 1: 673-682
111. Hamel W, Westphal M, Szonyi E, Escandon E, Nikolics K (1993) Neurotrophin gene expression by cell lines derived from human gliomas. J Neurosci Res 34: 147-157
112. Hammacher A, Hellman U, Johnsson A, Ostman A, Gunnarsson K, Westermark B, Wasteson A et al (1988) A major part of platelet-derived growth factor purified from human platelets is a heterodimer of one A and one B chain. J Biol Chem 263: 16493-16498
113. Hammacher A, Nister M, Westermark B, Heldin CH (1988) A human glioma cell line secretes three structurally and functionally different dimeric forms of platelet-derived growth factor. Eur J Biochem 176: 179-186
114. Harsh GR, Keating MT, Escobedo JA, Williams LT (1990) Platelet derived growth factor (PDGF) autocrine components in human tumour cell lines. J Neurooncol 8: 1-12
115. Hart CE, Forstrom JW, Kelly JD, Seifert RA, Smith RA, Ross R, Murray MJ et al (1988) Two classes of PDGF receptor recognize different isoforms of PDGF. Science 240: 1529-1531
116. Hayashi Y, Ueki K, Waha A, Wiestler OD, Louis DN, von Deimling A (1997) Association of EGFR gene amplification and CDKN2 (p16/MTS1) gene deletion in glioblastoma multiforme. Brain Pathol 7: 871-875
117. Hayes C, Kelly D, Murayama S, Komiyama A, Suzuki K, Popko B (1992) Expression of the neu oncogene under the transcriptional control of the myelin basic protein gene in transgenic mice: generation of transformed glial cells. J Neurosci Res 31: 175-187
118. Heldin CH (1995) Dimerization of cell surface receptors in signal transduction. Cell 80: 213-223
119. Heldin CH, Backstrom G, Ostman A, Hammacher A, Ronnstrand L, Rubin K, Nister M et al (1988) Binding of different dimeric forms of PDGF to human fibroblasts: evidence for two separate receptor types. EMBO J 7: 1387-1393
120. Heldin CH, Ostman A, Ronnstrand L (1998) Signal transduction via platelet-derived growth factor receptors. Biochim Biophys Acta 1378: F79-113
121. Hermanson M, Funa K, Hartman M, Claesson-Welsh L, Heldin CH, Westermark B, Nister M (1992) Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res 52: 3213-3219
122. Hermanson M, Funa K, Koopmann J, Maintz D, Waha A, Westermark B, Heldin CH et al (1996) Association of loss of heterozygosity on chromosome 17p with high platelet-derived growth factor alpha receptor expression in human malignant gliomas. Cancer Res 56: 164-171
123. Hermansson M, Nister M, Betsholtz C, Heldin CH, Westermark B, Funa K (1988) Endothelial cell hyperplasia in human glioblastoma: coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation. Proc Natl Acad Sci USA 85: 7748-7752
124. Hiesiger EM, Hayes RL, Pierz DM, Budzilovich GN (1993) Prognostic relevance of epidermal growth factor receptor (EGF-R) and c-neu/erbB2 expression in glioblastomas (GBMs). J Neurooncol 16: 93-104
125. Hines SJ, Organ C, Kornstein MJ, Krystal GW (1995) Coexpression of the c-kit and stem cell factor genes in breast carcinoma. Cell Growth Diff 6: 769-779
126. Hirose Y, Kojima M, Sagoh M, Murakami H, Yoshida K, Shimazaki K, Kawase T (1998) Immunohistochemical examination of c-Met protein expression in astrocytic tumours. Acta Neuropathol 95: 345-351
127. Ho WH, Armanini MP, Nuijens A, Phillips HS, Osheroff PL (1995) Sensory and motor neuron-derived factor. A novel heregulin variant highly expressed in sensory and motor neurons. J Biol Chem 270: 14523-14532
128. Holgado-Madruga M, Emlet DR, Moscatello DK, Godwin AK, Wong AJ (1996) A Grb2-associated docking protein in EGF- and insulin-receptor signalling. Nature 379: 560-564
129. Holmes WE, Sliwkowski MX, Akita RW, Henzel WJ, Lee J, Park JW, Yansura D et al (1992) Identification of heregulin, a specific activator of p185erbB2. Science 256: 1205-1210
130. Hongo A, Yumet G, Resnicoff M, Romano G, O'Connor R, Baserga R (1998) Inhibition of tumourigenesis and induction of apoptosis in human tumour cells by the stable expression of a myristylated COOH terminus of the insulin-like growth factor I receptor. Cancer Res 58: 2477-2484
131. Huang HS, Nagane M, Klingbeil CK, Lin H, Nishikawa R, Ji XD, Huang CM et al (1997) The enhanced tumourigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling. J Biol Chem 272: 2927-2935
132. Humphrey PA, Wong AJ, Vogelstein B, Friedman HS, Werner MH, Bigner DD, Bigner SH (1988) Amplification and expression of the epidermal growth factor receptor gene in human glioma xenografts. Cancer Res 48: 2231-2238
133. Hurtt MR, Moossy J, Donovan-Peluso M, Locker J (1992) Amplification of epidermal growth factor receptor gene in gliomas: histopathology and prognosis. J Neuropathol Exp Neurol 51: 84-90
134. Hynes NE, Stern DF (1994) The biology of erbB-2/neu/HER-2 and its role in cancer. Biochim Biophys Acta 1198: 165-184
135. Ikeda E, Achen MG, Breier G, Risau W (1995) Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J Biol Chem 270: 19761-19766
136. Jachimczak P, Hessdorfer B, Fabel-Schulte K, Wismeth C, Brysch W, Schlingensiepen KH, Bauer A et al (1996) Transforming growth factor-beta-mediated autocrine growth regulation of gliomas as detected with phosphorothionate antisense oligonucleotides. Int J Cancer 65: 332-337
137. Jannot CB, Beerli RR, Mason S, Gullick WJ, Hynes NE (1996) Intracellular expression of a single-chain antibody directed to the EGFR leads to growth inhibition of tumour cells. Oncogene 13: 275-282
138. Jaros E, Perry RH, Adam L, Kelly PJ, Crawford PJ, Kalbag RM, Mendelow AD et al (1992) Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours. Br J Cancer 66: 373-385
139. Jeffers M, Rong S, Vande-Woude GF (1996) Enhanced tumourigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network. Mol Cell Biol 16: 1115-1125
140. Jo SA, Zhu X, Marchionni MA, Burden SJ (1995) Neuregulins are concentrated at nerve-muscle synapses and activate ACh-receptor gene expression. Nature 373: 158-161
141. Jung W, Castren E, Odenthal M, Vande Woude GF, Ishii T, Dienes HP, Lindholm D et al (1994) Expression and functional interaction of hepatocyte growth factor-scatter factor and its receptor c-met in mammalian brain. J Cell. Biol. 126: 485-494
142. Kadle R, Suksang C, Roberson ED, Fellows RE (1988) Identification of an insulin-like factor in astrocyte conditioned medium. Brain Res 460: 60-67
143. Kaleko M, Rutter WJ, Miller AD (1990) Overexpression of the human insulinlike growth factor I receptor promotes ligand-dependent neoplastic transformation. Mol Cell Biol 10: 464-473
144. Kanda H, Tajima H, Lee GH, Nomura K, Ohtake K, Matsumolo K, Nakamura T et al (1993) Hepatocyte growth factor transforms immortalized mouse liver epithelial cells. Onocgene 8: 3047-3053
145. Karunagaran D, Tzahar E, Beerli RR, Chen X, Graus-Porta D, Ratzkin BJ, Seger R et al (1996) ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer. EMBO J 15: 254-264
146. Keating MT, Williams LT (1988) Autocrine stimulation of intracellular PDGF receptors in v-sis-transformed cells. Science 239: 914-916
147. Khazaie K, Schirrmacher V, Lichtner RB (1993) EGF receptor in neoplasia and metastasis. Cancer Metastasis Rev 12: 255-274
148. Kieser A, Weich HA, Brandner G, Marme D, Kolch W (1994) Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor/vascular permeability factor in brain tumour tissue and cyst fluid. Oncogene 9: 963-969
149. Kiess W, Lee L, Graham DE, Greenstein L, Tseng LY, Rechler MM, Nissley SP (1989) Rat C6 glial cells synthesize insulin-like growth factor I (IGF-I) and express IGF-I receptors and IGF-II/mannose 6-phosphate receptors. Endocrinology 124: 1727-1736
150. King CR, Borrello I, Bellot F, Comoglio P, Schlessinger J (1988) Egf binding to its receptor triggers a rapid tyrosine phosphorylation of the erbB-2 protein in the mammary tumour cell line SK-BR-3. EMBO J 7: 1647-1651
151. Kleihues P, Burger PC, Scheithauer BW (1993) The new WHO classification of brain tumours. Brain Pathol 3: 255-268
152. Kleihues P, Cavenee WK (1997) Pathology and Genetics of tumours of the nervous system. IARCPress, Lyon, France
153. Kleihues P, Ohgahki H (1997) Genetics of Glioma Progression and the Definition of primary and secondary glioblastomas. Brain Pathololgy 7: 1131-1136
154. Kokai Y, Myers JN, Wada T, Brown VI, LeVea CM, Davis JG, Dobashi K et al (1989) Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts. Cell 58: 287-292
155. Koochekpour S, Jeffers M, Rulong S, Taylor G, Klineberg E, Hudson EA, Resau JH et al (1997) Met and hepatocyte growth factor expression in human gliomas. Cancer Res 57: 5391-5398
156. Koochekpour S, Merzak A, Pilkington GJ (1995) Extracellular matrix proteins inhibit proliferation, upregulate migration and induce morphological changes in human glioma cell lines. Eur J Cancer 31: 375-380
157. Kraus MH, Issing W, Miki T, Popescu NC, Aaronson SA (1989) Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumours. Proc Natl Acad Sci USA 86: 9193-9197
158. Kristt DA, Reedy E, Yarden Y (1993) Receptor tyrosine kinase expression in astrocytic lesions: similar features in gliosis and glioma. Neurosurg 33: 106-115
159. Kumabe T, Sohma Y, Kayama T, Yoshimoto T, Yamamoto T (1992) Amplification of alpha-platelet-derived growth factor receptor gene lacking an exon coding for a portion of the extracellular region in a primary brain tumour of glial origin. Oncogene 7: 627-633
160. Kuppner MC, Hamou MF, Bodmer S, Fontana A, de Tribolet N (1988) The glioblastoma-derived T-cell suppressor factor/ transforming growth factor beta 2 inhibits the generation of lymphokine-activated killer (LAK) cells. Int J Cancer 42: 562-567
161. Kuratsu J, Sato K, Saitoh Y, Takeshima H, Morioka M, Ushio Y (1995) The mechanism of growth-regulation of glioma cells by trapidil. J Neurooncol 23: 201-206
162. Kuratsu J, Ushio Y (1990) Antiproliferative effect of trapidil, a platelet-derived growth factor antagonist, on a glioma cell line in vitro. J Neurosurg 73: 436-440
163. Lafarge-Frayssinet C, Duc HT, Frayssinet C, Sarasin A, Anthony D, Guo Y, Trojan J (1997) Antisense insulin-like growth factor I transferred into a rat hepatoma cell line inhibits tumourigenesis by modulating major histocompatibility complex I cell surface expression. Cancer Gene Ther 4: 276-285
164. Laird AD, Brown PI, Fausto N (1994) Inhibition of tumour growth in liver epithelial cells transfected with a transforming growth factor alpha antisense gene. Cancer Res 54: 4224-4232
165. Lamszus K, Schmidt NO, Jin L, Laterra J, Zagzag D, Way D, Witte M et al (1998) Scatter factor promotes motility of human glioma and neuromicrovascularendothelial cells. Int J Cancer 75: 19-28
166. Lang FF, Miller DC, Koslow M, Newcomb EW (1994) Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumours. J Neurosurg 81: 427-436
167. Lappi DA (1995) Tumour targeting through fibroblast growth factor receptors. Semin Cancer Biol 6: 279-288
168. LaRochelle WJ, Giese N, May-Siroff M, Robbins KC, Aaronson SA (1990) Molecular localization of the transforming and secretory properties of PDGF A and PDGF B. Science 248: 1541-1544
169. Laterra J, Nam M, Rosen EM, Rao JS, Lamszus K, Goldberg ID, Johnston P (1997) Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo. Lab Invest 76: 565-577
170. Leenstra S, Oskam NT, Bijleveld EH, Bosch DA, Troost D, Hulsebos TJ (1998) Genetic sub-types of human malignant astrocytoma correlate with survival. Int J Cancer 79: 159-165
171. Lemmon MA, Schlessinger J (1994) Regulation of signal transduction and signal diversity by receptor oligomerization. Trends Biochem Sci 19: 459-463
172. Lenoir D, Honegger P (1983) Insulin-like growth factor I (IGF I) stimulates DNA synthesis in fetal rat brain cell cultures. Brain Res 283: 205-213
173. Lens PF, Altena B, Nusse R (1986) Expression of c-sis and platelet-derived growth factor in in vitro-transformed glioma cells from rat brain tissue transplacentally treated with ethylnitrosourea. Mol Cell Biol 6: 3537-3540
174. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309
175. Lev S, Givol D, Yarden Y (1991) A specific combination of substrates is involved in signal transduction by the kit-encoded receptor. EMBO J 10: 647-654
176. Levi AD, Bunge RP, Lofgren JA, Meima L, Hefti F, Nikolics K, Sliwkowski MX (1995) The influence of heregulins on human Schwann cell proliferation. J Neurosci 15: 1329-1340
177. Lewis GD, Lofgren JA, McMurtrey AE, Nuijens A, Fendly BM, Bauer KD, Sliwkowski MX (1996) Growth regulation of human breast and ovarian tumour cells by heregulin: Evidence for the requirement of ErbB2 as a critical component in mediating heregulin responsiveness. Cancer Res 56: 1457-1465
178. Li W, Park JW, Nuijens A, Sliwkowski MX, Keller GA (1996) Heregulin is rapidly translocated to the nucleus and its transport is correlated with c-myc induction in breast cancer cells. Oncogene 12: 2473-2477
179. Libermann TA, Nusbaum HR, Razon N, Kris R, Lax I, Soreq H, Whittle N et al (1985) Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature 313: 144-147
180. Libermann TA, Razon N, Bartal AD, Yarden Y, Schlessinger J, Soreq H (1984) Expression of epidermal growth factor receptors in human brain tumours. Cancer Res 44: 753-760
181. Lorimer IA, Keppler-Hafkemeyer A, Beers RA, Pegram CN, Bigner DD, Pastan I (1996) Recombinant immunotoxins specific for a mutant epidermal growth factor receptor: targeting with a single chain antibody variable domain isolated by phage display. Proc Natl Acad Sci USA 93: 14815-14820
182. Louis DN (1997) A molecular genetic model of astrocytoma histopathology. Brain Pathol 7: 755-764
183. Louis DN, Gusella JF (1995) A tiger behind many doors: multiple genetic pathways to malignant glioma. Trends Genet 11: 412-415
184. Lund-Johansen M, Bjerkvig R, Humphrey PA, Bigner SH, Bigner DD, Laerum OD (1990) Effect of epidermal growth factor on glioma cell growth, migration, and invasion in vitro. Cancer Res 50: 6039-6044
185. Lund-Johansen M, Engebraaten O, Bjerkvig R, Laerum OD (1990) Invasive glioma cells in tissue culture. Anticancer Res 10: 1135-1351 7
186. Macaulay VM (1992) Insulin-like growth factors and cancer. Br J Cancer 65: 311-3 20
187. Maiden LT, Novak U, Kaye AH, Burgess AW (1988) Selective amplification of the cytoplasmic domain of the epidermal growth factor receptor gene in glioblastoma multiforme. Cancer Res 48: 2711-2714
188. Marchionni MA, Goodearl AD, Chen MS, Bermingham-McDonogh O, Kirk C, Hendricks M, Danehy F et al (1993) Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system. Nature 362: 312-318
189. Marshall CJ (1995) Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80: 179-185
190. Matsuda R, Takahashi T, Nakamura S, Sekido Y, Nishida K, Seto M, Seito T et al (1993) Expression of the c-kit protein in human solid tumours and in corresponding fetal and adult normal tissues. Am J Pathol 142: 339-346
191. Matsui T, Heidaran M, Miki T, Popescu N, La Rochelle W, Kraus M, Pierce J et al (1989) Isolation of a novel receptor cDNA establishes the existence of two PDGF receptor genes. Science 243: 800-804
192. Maxwell M, Galanopoulos T, Neville-Golden J, Hedley-Whyte ET, Antoniades HN (1998) Cellular localization of PDGF mRNAs in developing human forebrain. Neuropathol Appl Neurobiol 24: 337-345
193. Maxwell M, Naber SP, Wolfe H, Galanopoulos T, Hedley-Whyte ET, Black PM, Antoniades HN (1990) Coexpression of platelet-derived growth factor (PDGF) and PDGF-receptor genes by primary human astrocytomas may contribute to their development and maintenance. J Clin Invest 86: 131-140
194. McCusker RH, Camacho-Hubner C, Bayne ML, Cascieri MA, Clemmons DR (1990) Insulin-like growth factor (IGF) binding to human fibroblast and glioblastoma cells: the modulating effect of cell released IGF binding proteins (IGFBPs). J Cell Physiol 144: 244-253
195. McMorris FA, Smith TM, DeSalvo S, Furlanetto RW (1986) Insulin-like growth factor I/somatomedin C: a potent inducer of oligodendrocyte development. Proc Natl Acad Sci USA 83: 822-826
196. Mercola M, Deininger PL, Shaman SM, Porter J, Wang CY, Stiles CD (1990) Dominant-negative mutants of a platelet-derived growth factor gene. Genes Dev 4: 2333-2341
197. Merrill MJ, Edwards NA (1990) Insulin-like growth factor-I receptors in human glial tumours. J Clin Endocrinol Metab 71: 199-209
198. Merzak A, McCrea S, Koocheckpour S, Pilkington GJ (1994) Control of human glioma cell growth, migration and invasion in vitro by transforming growth factor beta 1. Br J Cancer 70: 199-203
199. Meyer D, Birchmeier C (1994) Distinct isoforms of neuregulin are expressed in mesenchymal and neuronal cells during mouse development. Proc Natl Acad Sci USA 91: 1064-1068
200. Meyer D, Birchmeier C (1995) Multiple essential functions of neuregulin in development. Nature 378: 386-390
201. Millauer B, Longhi MP, Plate KH, Shawver LK, Risau W, Ullrich A, Strawn LM (1996) Dominant-negative inhibition of Flk-1 suppresses the growth of many tumour types in vivo. Cancer Res 56: 1615-1620
202. Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A (1994) Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 367: 576-579
203. Millauer B, Wizigmann-Voos S, Schnurch H, Martinez R, Moller NP, Risau W, Ullrich A (1993) High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72: 835-846
204. Minchenko A, Salceda S, Bauer T, Caro J (1994) Hypoxia regulatory elements of the human vascular endothelial growth factor gene. Cell Mol Biol Res 40: 35-39
205. Montgomery RB, Moscatello DK, Wong AJ, Cooper JA, Stahl WL (1995) Differential modulation of mitogen-activated protein (MAP) kinase/extracellular signal-related kinase kinase and MAP kinase activities by a mutant epidermal growth factor receptor. J Biol Chem 270: 30562-30566
206. Moriyama T, Kataoka H, Hamasuna R, Yokogami K, Uehara H, Kawano H, Goya T et al (1998) Up-regulation of vascular endothelial growth factor induced by hepatocyte growth factor/scatter factor stimulation in human glioma cells. Biochem Biophys Res Commun 249: 73-77
207. Moriyama T, Kataoka H, Seguchi K, Tsubouchi H, Koono M (1996) Effects of hepatocyte growth factor (HGF) on human glioma cells in vitro: HGF acts as a motility factor in glioma cells. Int J Cancer 66: 678-685
208. Moriyama T, Kataoka H, Tsubouchi H, Koono M (1995) Concomitant expression of hepatocyte growth factor (HGF), HGF activator and c-met genes in human glioma cells in vitro. FEBS Lett 372: 78-82
209. Morrison R, Yamaguchi F, Bruner JM, Tang M, McKeehan W, Berger MS (1994) Fibroblast growth factor receptor gene expression and immunoreactivity are elevated in human glioblastoma multiforme. Cancer Res 54: 2794-2799
210. Morrison RS (1991) Suppression of basic fibroblast growth factor expression by antisense oligonucleotides inhibits the growth of transformed human astrocytes. J Biol Chem 266: 728-734
211. Morrison RS, Gross JL, Herblin WF, Reilly TM, LaSala PA, Alterman RL, Moskal JR et al (1990) Basic fibroblast growth factor-like activity and receptors are expressed in a human glioma cell line. Cancer Res 50: 2524-2529
212. Morrison RS, Yamaguchi F, Saya H, Bruner JM, Yahanda AM, Donehower LA, Berger M (1994) Basic fibroblast growth factor and fibroblast growth factor receptor I are implicated in the growth of human astrocytomas. J Neurooncol 18: 207-216
213. Morrissey TK, Levi AD, Nuijens A, Sliwkowski MX, Bunge RP (1995) Axon-induced mitogenesis of human Schwann cells involves heregulin and p185erbB2. Proc Natl Acad Sci USA 92: 1431-1435
214. Moscatello DK, Holgado-Madruga M, Emlet DR, Montgomery RB, Wong AJ (1998) Constitutive activation of phosphatidylinositol 3-kinase by a naturally occurring mutant epidermal growth factor receptor. J Biol Chem 273: 200-206
215. Moscatello DK, Montgomery RB, Sundareshan P, McDanel H, Wong MY, Wong AJ (1996) Transformational and altered signal transduction by a naturally occurring mutant EGF receptor. Oncogene 13: 85-96
216. Mukhopadhyay D, Tslokas L, Zhou X-M, Foster D, Brugge JS, Sukhatme VP (1995) Hypoxic induction of human vascular endothelial growth factor expression through c-src activation. Nature 375: 577-580
217. Murali R, Brennan PJ, Kieber-Emmons T, Greene MI (1996) Structural analysis of p185c-neu and epidermal growth factor receptor tyrosine kinases: oligomerization of kinase domains. Proc Natl Acad Sci USA 93: 6252-6257
218. Murphy PR, Sato Y, Knee RS (1992) Phosphorothioate antisense oligonucleotides against basic fibroblast growth factor inhibit anchorage-dependent and anchorage-independent growth of a malignant glioblastoma cell line. Mol Endocrinol 6: 877-884
219. Nagane M, Coufal F, Lin H, Bogler O, Cavenee WK, Huang HJ (1996) A common mutant epidermal growth factor receptor confers enhanced tumourigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis. Cancer Res 56: 5079-5086
220. Nagane M, Levitzki A, Gazit A, Cavenee WK, Huang HS (1998) Drug resistance of human glioblastoma cells conferred by a tumour-specific mutant epidermal growth factor receptor through modulation of bcl-XL and caspase-3-like proteases. Proc Natl Acad Sci USA 95: 5724-5729
221. Nakano A, Tani E, Miyazaki K, Yamamoto Y, Furuyama J (1995) Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. J Neurosurg 83: 298-307
222. Natali PG, Nicotra MR, Sures I, Santoro E, Bigotti A, Ullrich A (1992) Expression of c-kit receptor in normal and transformed human non-lymphoid tissues. Cancer Res 52: 6139-6143
223. Ness GO, Haugen DR, Varhaug JE, Akslen LA, Lillehaug JR (1996) Cytoplasmic localization of EGF receptor in papillary thyroid carcinomas: association with the 150-kDa receptor form. Int J Cancer 65: 161-167
224. Nishikawa R, Ji XD, Harmon RC, Lazar CS, Gill GN, Cavenee WK, Huang HJ (1994) A mutant epidermal growth factor receptor common in human glioma confers enhanced tumourigenicity. Proc Natl Acad Sci USA 91: 7727-7731
225. Nister M, Claesson-Welsh L, Eriksson A, Heldin CH, Westermark B (1991) Differential expression platelet-derived growth factor receptors in human malignant glioma cell lines. J Biol Chem: 266: 16755-16763
226. Nister M, Hammacher A, Mellstrom K, Siegbahn A, Ronnstrand L, Westermark B, Heldin CH (1988) A glioma-derived PDGF A chain homodimer has different functional activities from a PDGF AB heterodimer purified from human platelets. Cell 52: 791-799
227. Nister M, Libermann TA, Betsholtz C, Pettersson M, Claesson-Welsh L, Heldin CH, Schlessinger J et al (1988) Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-alpha and their receptors in human malignant glioma cell lines. Cancer Res 48: 3910-3918
228. Nitta T, Sato K (1994) Specific inhibition of c-sis protein synthesis and cell proliferation with antisense oligodeoxynucleotides in human glioma cells. Neurosurgery 34: 309-315
229. Noble M, Murray K, Stroobant P, Waterfield MD, Riddle P (1988) Platelet-derived growth factor promotes division and motility and inhibitspremature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell. Nature 333: 560-562
230. Nordqvist AC, Skwirut CC, Ehrenborg E, Grissom FE, Sara VR (1993) Comparison of insulin-like growth factors and their binding proteins in glioblastoma and neuroblastoma cells. Ann N Y Acad Sci 692: 297-299
231. Normanno N, Bianco C, Damiano V, de A, E., Selvam MP, Grassi M, Magliulo G et al (1996) Growth Inhibition of Human Colon Carcinoma Cells by Combinations of Anti-Epidermal Growth Factor-related Growth Factor Antisense Oligonucleotides. Clin Cancer Res 2: 601-609
232. O'Rourke DM, Nute EJ, Davis JG, Wu C, Lee A, Murali R, Zhang HT et al (1998) Inhibition of a naturally occurring EGFR oncoprotein by the p185neu ectodomain: implications for subdomain contributions to receptor assembly. Oncogene 16: 1197-1207
233. Olson JJ, Barnett D, Yang J, Assietti R, Cotsonis G, James CD (1998) Gene amplification as a prognostic factor in primary brain tumours. Clin Cancer Res 4: 215-222
234. Ostman A, Rall L, Hammacher A, Wormstead MA, Coit D, Valenzuela P, Betsholtz C et al (1988) Synthesis and assembly of a functionally active recombinant platelet-derived growth factor AB heterodimer. J Biol Chem 263: 16202-16208
235. Pantazis P, Pelicci PG, Dalla-Favera R, Antoniades HN (1985) Synthesis and secretion of proteins resembling platelet-derived growth factor by human glioblastoma and fibrosarcoma cells in culture. Proc Natl Acad Sci USA 82: 2404-2408
236. Pedersen PH, Ness GO, Engebraaten O, Bjerkvig R, Lillehaug JR, Laerum OD (1994) Heterogeneous response to the growth factors [EGF, PDGF (bb), TGF-alpha, bFGF, IL-2] on glioma spheroid growth, migration and invasion. Int J Cancer 56: 255-261
237. Peles E, Bacus SS, Koski RA, Lu HS, Wen D, Ogden SG, Levy RB et al (1992) Isolation of the neu/HER-2 stimulatory ligand: a 44 kd glycoprotein that induces differentiation of mammary tumour cells. Cell 69: 205-216
238. Pepper MS, Ferrara N, Orci L, Montesano R (1992) Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun 189: 824-831
239. Perantoni AO, Rice JM, Reed CD, Watatani M, Wenk ML (1987) Activated neu oncogene sequences in primary tumours of the peripheral nervous system induced in rats by transplacental exposure to ethylnitrosurea. Proc Natl Acad Sci 84: 6317-6321
240. Peters KG, De Vries C, Williams LT (1993) Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci USA 90: 8915-8919
241. Peterson JE, Jelinek T, Kaleko M, Siddle K, Weber MJ (1994) c phosphorylation and activation of the IGF-I receptor in src-transformed cells. J Biol Chem 269: 27315-27321
242. Pham CD, Roberts TP, van Bruggen N, Melnyk O, Mann J, Ferrara N, Cohen RL et al (1998) Magnetic resonance imaging detects suppression of tumour vascular permeability after administration of antibody to vascular endothelial growth factor. Cancer Invest 16: 225-230
243. Phillips HS, Armani MP, Stavrou D, Ferrara N, Westphal M (1993) Intense local expression of vascular endothelial growth factor mRNA in human intracranial neoplasms: association with regions of necrosis. Int J Oncol 2: 913-919
244. Phillips PC, Levow C, Catterall M, Colvin OM, Pastan I, Brem H (1994) Transforming growth factor-alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE38) treatment of subcutaneous and intracranial human glioma and medulloblastoma xenografts in athymic mice. Cancer Res 54: 1008-1015
245. Pietrzkowski Z, Sell C, Lammers R, Ullrich A, Baserga R (1992) Roles of insulinlike growth factor 1 (IGF-I) and the IGF-1 receptor in epidermal growth factor-stimulated growth of 3T3 cells. Mol Cell Biol 12: 3883-3889
246. Pietsch T, Valter MM, Wolf HK, von Deimling A, Huang HJ, Cavenee WK, Wiestler OD (1997) Expression and distribution of vascular endothelial growth factor protein in human brain tumours. Acta Neuropathol (Berl) 93: 109-117
247. Pigott TJ, Robson DK, Palmer J, Ward LM (1993) Expression of epidermal growth factor receptor in human glioblastoma multiforme. Br J Neurosurg 7: 261-265
248. Pinkas-Kramarski R, Eilam R, Alroy I, Levkowitz G, Lonai P, Yarden Y (1997) Differential expression of NDF/neuregulin receptors ErbB-3 and ErbB-4 and involvement in inhibition of neuronal differentiation. Oncogene 15: 2803-2815
249. Pinkas-Kramarski R, Eilam R, Spiegler O, Lavi S, Liu N, Chang D, Wen D et al (1994) Brain neurons and glial cells express Neu differentiation factor/heregulin: a survival factor for astrocytes. Proc Natl Acad Sci USA 91: 9387-9391
250. Pinkas-Kramarski R, Soussan L, Waterman H, Levkowitz G, Alroy I, Klapper L, Lavi S et al (1996) Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. EMBO J 15: 2452-2467
251. Plate KH, Breier G, Farrell CL, Risau W (1992) Platelet-derived growth factor receptor-beta is induced during tumour development and upregulated during tumour progression in endothelial cells in human gliomas. Lab Invest 67: 529-534
252. Plate KH, Breier G, Millauer B, Ullrich A, Risau W (1993) Upregulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumour angiogenesis. Cancer Res 53: 5822-5827
253. Plate KH, Breier G, Weich HA, Mennel HD, Risau W (1994) Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int J Cancer 59: 520-529
254. Plate KH, Breier G, Weich HA, Risau W (1992) Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359: 845-848
255. Plate KH, Risau W (1995) Angiogenesis in malignant gliomas. Glia 15: 339-347
256. Plate KH, Warnke PC (1997) Vascular endothelial growth factor. J Neurooncol 35: 365-372
257. Plowman GD, Green JM, Culouscou JM, Carlton GW, Rothwell VM, Buckley S (1993) Heregulin induces tyrosine phosphorylation of HER4/p180erbB4. Nature 366: 473-475
258. Pollack IF, Randall MS, Kristofik MP, Kelly RH, Selker RG, Vertosick FTJ (1991) Response of low-passage human malignant gliomas in vitro to stimulation and selective inhibition of growth factor-mediated pathways. J Neurosurg 75: 284-293
259. Potapova O, Fakhrai H, Baird S, Mercola D (1996) Platelet-derived growth factor-B/v-sis confers a tumourigenic and metastatic phenotype to human T98G glioblastoma cells. Cancer Res 56: 280-286
260. Potapova O, Fakhrai H, Mercola D (1996) Growth factor PDGF-B/v-sis confers a tumourigenic phenotype to human tumour cells bearing PDGF receptors but not to cells devoid of receptors: evidence for an autocrine, but not a paracrine, mechanism. Int J Cancer 66: 669-677
261. Prager D, Li HL, Asa S, Melmed S (1994) Dominant negative inhibition of tumourigenesis in vivo by human insulin-like growth factor I receptor mutant. Proc Natl Acad Sci USA 91: 2181-2185
262. Prigent SA, Nagane M, Lin H, Huvar I, Boss GR, Feramisco JR, Cavenee WK et al (1996) Enhanced tumourigenic behavior of glioblastoma cells expressing a truncated epidermal growth factor receptor is mediated through the Ras-Shc-Grb2 pathway. J Biol Chem 271: 25639-25645
263. Pringle N, Collarini EJ, Mosley MJ, Heldin CH, Westermark B, Richardson WD (1989) PDGF A chain homodimers drive proliferation of bipotential (O-2A) glial progenitor cells in the developing rat optic nerve. EMBO J 8: 1049-1056
264. Qiu FH, Ray P, Brown K, Barker PE, Jhanwar S, Ruddle FH, Besmer P (1988) Primary structure of c-kit: relationship with the CSF-1/PDGF receptor kinase family-oncogenic activation of v-kit involves deletion of extracellular domain and C terminus. EMBO J 7: 1003-1011
265. Quinn TP, Peters KG, De Vries C, Ferrara N, Williams LT (1993) Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc Natl Acad Sci USA 90: 7533-7537
266. Raff MC, Lillien LE, Richardson WD, Burne JF, Noble MD (1988) Platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture. Nature 333: 562-565
267. Rainov NG, Dobberstein KU, Bahn H, Holzhausen HJ, Lautenschlager C, Heidecke V, Burkert W (1997) Prognostic factors in malignant glioma: influence of the overexpression of oncogene and tumour-suppressor gene products on survival. J Neurooncol 35: 13-28
268. Redekop GJ, Naus CC (1995) Transfection with bFGF sense and antisense cDNA resulting in modification of malignant glioma growth. J Neurosurg 82: 83-90
269. Reist CJ, Archer GE, Kurpad SN, Wikstrand CJ, Vaidyanathan G, Willingham MC, Moscatello DK et al (1995) Tumour-specific anti-epidermal growth factor receptor variant III monoclonal antibodies: use of the tyramine-cellobiose radio-iodination method enhances cellular retention and uptake in tumour xenografts. Cancer Res 55: 4375-4382
270. Resnicoff M, Baserga R (1998) The role of the insulin-like growth factor I receptor in transformation and apoptosis. Ann N Y Acad Sci 842: 76-81
271. Resnicoff M, Burgaud JL, Rotman HL, Abraham D, Baserga R (1995) Correlation between apoptosis, tumourigenesis, and levels of insulin-like growth factor I receptors. Cancer Res 55: 3739-3741
272. Resnicoff M, Coppola D, Sell C, Rubin R, Ferrone S, Baserga R (1994) Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin-like growth factor receptor. Cancer Res 54: 4848-4850
273. Resnicoff M, Li W, Basak S, Herlyn D, Baserga R, Rubin R (1996) Inhibition of rat C6 glioblastoma tumour growth by expression of insulin-like growth factor I receptor antisense mRNA. Cancer Immunol Immunother 42: 64-68
274. Resnicoff M, Sell C, Rubini M, Coppola D, Ambrose D, Baserga R, Rubin R (1994) Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-1 (IGF-1) receptor are nontumourigenic and induce regression of wild-type tumours. Cancer Res 54: 2218-2222
275. Richardson WD, Pringle N, Mosley MJ, Westermark B, Dubois-Dalcq M (1988) A role for platelet-derived growth factor in normal gliogenesis in the central nervous system. Cell 53: 309-319
276. Riese DJn, van Raaij TM, Plowman GD, Andrews GC, Stern DF (1995) The cellular response to neuregulins is governed by complex interactions of the erbB receptor family. Mol Cell Biol 15: 5770-5576
277. Rong S, Segal S, Anver M, Resau JH, Vande-Woude GF (1994) Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation. Proc Natl Acad Sci USA 91: 4731-4735
278. Rosen EM, Laterra J, Joseph A, Jin L, Fuchs A, Way D, Witte M et al (1996) Scatter factor expression and regulation in human glial tumours. Int J Cancer 67: 248-255
279. Rosenthal A, Lindquist PB, Bringman TS, Goeddel DV, Derynck R (1986) Expression in rat fibroblasts of a human transforming growth factor-alpha cDNA results in transformation. Cell 46: 301-309
280. Rubin R, Baserga R (1995) Insulin-like growth factor-I receptor. Its role in cell proliferation, apoptosis, and tumourigenicity. Lab Invest 73: 311-331
281. Saleh M, Stacker SA, Wilks AF (1996) Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. Cancer Res 56: 393-401
282. Samoto K, Ikezaki K, Ono M, Shono T, Kohno K, Kuwano M, Fukui M (1995) Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumours. Cancer Res 55: 1189-1193
283. Sandberg AC, Engberg C, Lake M, von Holst H, Sara VR (1988) The expression of insulin-like growth factor I and insulin-like growth factor II genes in the human fetal and adult brain and in glioma. Neurosci Lett 93: 114-119
284. Sandberg-Nordqvist AC, Stahlbom PA, Reinecke M, Collins VP, von Holst H, Sara V (1993) Characterization of insulin-like growth factor 1 in human primary brain tumours. Cancer Res 53: 2475-2478
285. Saneto RP, de Vellis J (1985) Characterization of cultured rat oligodendrocytes proliferating in a serum-free, chemically defined medium. Proc Natl Acad Sci USA 82: 3509-2313
286. Sara VR, Carlsson-Skwirut C (1988) The role of the insulin-like growth factors in the regulation of brain development. Prog Brain Res 73: 87-99
287. Saxena A, Ali IU (1992) Increased expression of genes from growth factor signaling pathways in glioblastoma cell lines. Oncogene 7: 243-247
288. Schechter AL, Stern DF, Vaidyanathan L, Decker SJ, Drebin JA, Greene MI, Weinberg RA (1984) The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen. Nature 312: 513-516
289. Schlegel J, Merdes A, Stumm G, Albert FK, Forsting M, Hynes N, Kiessling M (1994) Amplification of the epidermal-growth-factor-receptor gene correlates with different growth behaviour in human glioblastoma. Int J Cancer 56: 72-77
290. Schlegel J, Stumm G, Brandle K, Merdes A, Mechtersheimer G, Hynes NE, Kiessling M (1994) Amplification and differential expression of members of lhe erbB-gene family in human glioblastoma. J Neurooncol 22: 201-207
291. Schlegel U, Moots PL, Rosenblum MK, Thaler HT, Furneaux HM (1990) Expression of transforming growth factor alpha in human gliomas. Oncogene 5: 1839-1842
292. Schmidt NO, Westphal M, Hagel C, Ergün S, Stavrou D, Rosen EM, Lamszus K (1999) Levels of Vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis. Int J Cancer 84: 10-18
293. Schwechheimer K, Huang S, Cavenee WK (1995) EGFR gene amplification-rearrangement in human glioblastomas. Int J Cancer 62: 145-148
294. Schwechheimer K, Laufle RM, Schmahl W, Knodlseder M, Fischer H, Hofler H (1994) Expression of neu/c-erbB-2 in human brain tumours. Hum Pathol 25: 772-780
295. Seetharam L, Gotoh N, Maru Y, Neufeld G, Yamaguchi S, Shibuya M (1995) A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene 10: 135-147
296. Segal RA, Goumnerova LC, Kwon YK, Stiles CD, Pomeroy SL (1994) Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma. Proc Natl Acad Sci USA 91: 12867-12871
297. Sell C, Baserga R, Rubin R (1995) Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis. Cancer Res 55: 303-306
298. Sell C, Dumenil G, Deveaud C, Miura M, Coppola D, DeAngelis T, Rubin R et al (1994) Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts. Mol Cell Biol 14: 3604-3612
299. Sell C, Rubini M, Rubin R, Liu JP, Efstratiadis A, Baserga R (1993) Simian virus 40 large tumour antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor. Proc Natl Acad Sci USA 90: 11217-11221
300. Shah NM, Marchionni MA, Isaacs I, Stroobant P, Anderson DJ (1994) Glial growth factor restricts mammalian neural crest stem cells to a glial fate. Cell 77: 349-360
301. Shamah SM, Stiles CD, Guha A (1993) Dominant-negative mutants of platelet-derived growth factor revert the transformed phenotype of human astrocytoma cells. Mol Cell Biol 13: 7203-7212
302. Shevelev A, Burfeind P, Schulze E, Rininsland F, Johnson TR, Trojan J, Chernicky CL et al (1997) Potential triple helix-mediated inhibition of IGF-I gene expression significantly reduces tumourigenicity of glioblastoma in an animal model. Cancer Gene Ther 4: 105-112
303. Shibuya M, Yamaguchi S, Yamane A, Ikeda T, Tojo A. Matsuhima H, Sato M (1990) Nucleotide sequence and expression of a novel human receptor-tyrosine kinase (flt) closely related to the fms family. Oncogene 5: 519-524
304. Shimasaki S, Shimonaka M, Zhang HP, Ling N (1991) Identification of five different insulin-like growth factor binding proteins (IGFBPs) from adult rat serum and molecular cloning of a novel IGFBP-5 in rat and human. J Biol Chem 266: 10646-10653
305. Shum L, Reeves SA, Kuo AC, Fromer ES, Derynck R (1994) Association of the transmembrane TGF-alpha precursor with a protein kinase complex. J Cell Biol 125: 903-916
306. Shweiki D, Itin A, Soffer D, Keshet E (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843-845
307. Shweiki D, Neeman M, Itin A, Keshet E (1995) Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumour angiogenesis. Proc Natl Acad Sci USA 92: 768-772
308. Siegall CB, FitzGerald DJ, Pastan I (1990) Selective killing of tumour cells using EGF or TGF alpha-Pseudomonas exotoxin chimeric molecules. Semin Cancer Biol 1: 345-350
309. Sizeland AM, Burgess AW (1992) Anti-sense transforming growth factor alpha oligonucleotides inhibit autocrine stimulated proliferation of a colon carcinoma cell line. Mol Biol Cell 3: 1235-1243
310. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177-182
311. Sliwkowski MX, Schaefer G, Akita RW, Lofgren JA, Fitzpatrick VD, Nuijens A, Fendly BM et al (1994) Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. J Biol Chem 269: 14661-14665
312. Soltoff SP, Carraway KLr, Prigent SA, Gullick WG, Cantley LC (1994) ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor. Mol Cell Biol 14: 3550-3558
313. Stan AC, Nemati MN, Pietsch T, Walter GF, Dietz H (1995) In vivo inhibition of angiogenesis and growth of the human U-87 malignant glial tumour by treatment with an antibody against basic fibroblast growth factor. J Neurosurgery 82: 1044-1052
314. Stanulla M, Welte K, Hadam MR, Pietsch T (1995) Coexpression of stem cell factor and its receptor c-kit in human malignant glioma cell lines. Acta Neuropathol (Berl) 89: 158-165
315. Steck PA, Lee P, Hung MC, Yung WK (1988) Expression of an altered epidermal growth factor receptor by human glioblastoma cells. Cancer Res 48: 5433-5439
316. Stefanik DF, Rizkalla LR, Soi A, Goldblatt SA, Rizkalla WM (1991) Acidic and basic fibroblast growth factors are present in glioblastoma multiforme. Cancer Res 51: 5760-5765
317. Stein I, Neeman M, Shweiki D, Itin A, Keshet E (1995) Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol Cell Biol 15: 5363-5368
318. Stemmer-Rachamimov AO, Louis DN (1997) Histopathologic and immunohistochemical prognostic factors in malignant gliomas. Curr Opin Oncol 9: 230-234
319. Stern DF, Kamps MP (1988) EGF-stimulated tyrosine phosphorylation of p185neu: a potential model for receptor interactions. EMBO J 7: 995-1001
320. Stoker M, Gherardi E, Perryman M, Gray J (1987) Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 327: 239-242
321. Stratmann A, Machein MR, Plate KH (1997) Anti-angiogenic gene therapy of malignant glioma. Acta Neurochir Suppl (Wien) 68: 105-110
322. Strawn LM, Mann E, Elliger SS, Chu LM, Germain LL, Niederfellner G, Ullrich A et al (1994) Inhibition of glioma cell growth by a truncated platelet-derived growth factor-beta receptor. J Biol Chem 269: 21215-21222
323. Strugar J, Rothbart D, Harrington W, Criscuolo GR (1994) Vascular permeability factor in brain metastases: correlation with vasogenic brain edema and tumour angiogenesis. J Neurosurg 81: 560-566
324. Sugawa N, Ekstrand AJ, James CD, Collins VP (1990) Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas. Proc Natl Acad Sci USA 87: 8602-8606
325. Tada M, Diserens AC, Desbaillets I, De Tribolet N (1994) Analysis of cytokine receptor messenger RNA expression in human glioblastoma cells and normal astrocytes by reverse-transcription polymerase chain reaction. J Neurosurg 80: 1063-1073
326. Takahashi JA, Fukumoto M, Igarashi K, Oda Y, Kikuchi H, Hatunaka M (1992) Correlation of basic fibroblast growth factor expression levels with the degree of malignancy and vascularity in human gliomas. J Neurosurg 76: 792-298
327. Takano S, Gately S, Engelhard H, Tsanaclis AM, Brem S (1994) Suramin inhibits glioma cell proliferation in vitro and in the brain. J Neurooncol 21: 189-201
328. Takano S, Gately S, Neville ME, Herblin WF, Gross JL, Engelhard H, Perricone M et al (1994) Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator. Cancer Res 54: 2654-2660
329. Tang P, Steck PA, Yung WK (1997) The autocrine loop of TGF-alpha/EGFR and brain tumours. J Neurooncol 35: 303-314
330. Terman BI, Dougher-Vermazen M, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz D, Bohlen P (1992) Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 187: 1579-1586
331. Torp SH, Helseth E, Dalen A, Unsgaard G (1992) Relationships between Ki-67 labelling index, amplification of the epidermal growth factor receptor gene, and prognosis in human glioblastomas. Acta Neurochir (Wien) 117: 182-186
332. Westermark B, Heldin CH, Nister M (1995) Platelet-derived growth factor in human glioma. Glia 15: 257-263
333. Westermark B, Magnusson A, Heldin CH (1982) Effect of epidermal growth factor on membrane motility and cell locomotion in cultures of human clonal glioma cells. J Neurosci Res 8: 491-507
334. Westphal M, Ackermann E, Hoppe J, Hermann HD (1991) Receptors for platelet derived growth factor in human glioma cell lines and influence of suramin on cell proliferation. J Neurooncol 11: 207-213
335. Westphal M, Brunken M, Rohde E, Hermann HD (1988) Growth factors in cultured human glioma cells: differential effects of FGF, EGF and PDGF. Cancer Lett 38: 283-296
336. Westphal M, Haensel M, Mueller D, Laas R, Kunzmann R, Rohde E, Koenig A et al (1988) Biological and karyotypic characterization of a new cell line derived from human gliosarcoma. Cancer Res 48: 731-740
337. Westphal M, Hamel W, Zirkel D, Herrmann HD, Bilzer T, Reifenberger G, Schober R et al (1994) Epidermal growth factor receptor expression in human malignant glioma: in vitro and in vivo effects of application of monoclonal antibodies to the epidermal growth factor receptor. Recent Results Cancer Res 135: 171-184
338. Westphal M, Hansel M, Hamel W, Kunzmann R, Holzel F (1994) Karyotype analyses of 20 human glioma cell lines. Acta Neurochir (Wien) 126: 17-26
339. Westphal M, Hansel M, Nausch H, Rohde E, Koppen J, Fiola M, Holzel F et al (1988) Glioma biology in vitro: goals and concepts. Acta Neurochir [Suppl] (Wien) 43: 107-113
340. Westphal M, Harsh GRt, Rosenblum ML, Hammonds RGJ (1985) Epidermal growth factor receptors in the human glioblastoma cell line SF268 differ from those in epidermoid carcinoma cell line A431. Biochem Biophys Res Commun 132: 284-289
341. Westphal M, Herrmann HD (1989) Growth factor biology and oncogene activation in human gliomas and their implications for specific therapeutic concepts. Neurosurgery 25: 681-694
342. Westphal M, Meima L, Szonyi E, Lofgren J, Meissner H, Hamel W, Nikolics K et al (1997) Heregulins and the ErbB-2/3/4 receptors in gliomas. J Neurooncol 35: 335-346
343. Wikstrand CJ, McLendon RE, Friedman AH, Bigner DD (1997) Cell surface localization and density of the tumour-associated variant of the epidermal growth factor receptor, EGFRvIII. Cancer Res 57: 4130-4140
344. Wong AJ, Bigner SH, Bigner DD, Kinzler KW, Hamilton SR, Vogelstein B (1987) Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci USA 84: 6899-6903
345. Wong AJ, Ruppert JM, Bigner SH, Grzeschik CH, Humphrey PA, Bigner DS, Vogelstein Bx (1992) Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc Natl Acad Sci USA 89: 2965-2969
346. Wrann M, Bodmer S, de Martin R, Siepl C, Hofer-Warbinek R, Frei K, Hofer E et al (1987) T cell suppressor factor from human glioblastoma cells is a 12.5-kd protein closely related to transforming growth factor-beta. EMBO J 6: 1633-1636
347. Yamada N, Kato M, Yamashita H, Nister M, Miyazono K, Heldin CH, Funa K (1995) Enhanced expression of transforming growth factor-beta and its type-I and type-II receptors in human glioblastoma. Int J Cancer 62: 386-392
348. Yamada T, Yoshiyama Y, Tsuboi Y, Shimomura T (1997) Astroglial expression of hepatocyte growth factor and hepatocyte growth factor activator in human brain tissues. Brain Res 762: 251-255
349. Yamazaki H, Fukui Y, Ueyama Y, Tamaoki N, Kawamoto T, Taniguchi S, Shibuya M (1988) Amplification of the structurally and functionally altered epidermal growth factor receptor gene (c-erbB) in human brain tumours. Mol Cell Biol 8: 1816-1820
350. Yamazaki H, Kijima H, Ohnishi Y, Abe Y, Oshika Y, Tsuchida T, Tokunaga T et al (1998) Inhibition of tumour growth by ribozyme-mediated suppression of aberrant epidermal growth factor receptor gene expression. J Natl Cancer Inst 90: 581-587
351. Yamazaki H, Ohba Y, Tamaoki N, Shibuya M (1990) A deletion mutation within the ligand binding domain is responsible for activation of epidermal growth factor receptor gene in human brain tumours. Jpn J Cancer Res 81: 773-779
352. Yarden Y, Escobedo JA, Kuang WJ, Yang-Feng TL, Daniel TO, Tremble PM, Chen EY et al (1986) Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors. Nature 323: 226-232
353. Yeh HJ, Ruit KG, Wang YX, Parks WC, Snider WD, Deuel TF (1991) PDGF A-chain gene is expressed by mammalian neurons during development and in maturity. Cell 64: 209-216
354. Yuan F, Chen Y, Dellian M, Safabakhsh N, Ferrara N, Jain RK (1996) Time-dependent vascular regression and permeability changes in established human tumour xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc Natl Acad Sci USA 93: 14765-14770
355. Zagzag D, Miller DC, Sato Y, Rifkin DB, Burstein DE (1990) Immunohistochemical localization of basic fibroblast growth factor in astrocytomas. Cancer Res 50: 7393-7398
356. Zhu A, Shaeffer J, Leslie S, Kolm P, El-Mahdi AM (1996) Epidermal growth factor receptor: an independent predictor of survival in astrocytic tumours given definitive irradiation. Int J Radiat Oncol Biol Phys 34: 809-815
357. Zumkeller W, Biernoth R, Kocialkowski S, Martinerie C, Schofield PN, Perbal B, Westphal M (1998) Expression and synthesis of insulin-like growth factor (IGF)-I, -II and their receptors in human glioma cell lines. Int J Oncol 9: 983-992
358. Zumkeller W, Muller D, Muller S, Gunther C, Westphal M (1998) Expression and synthesis of insulin-like growth factor-binding proteins in human glioma cell lines. Int J Oncol 12: 129-135